Advisory Committees

Roster of the Cellular, Tissue and Gene Therapies Advisory Committee

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 0 (as of 10/1/2018)

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson ****
Lisa Butterfield, Ph.D.
Expertise: Surgery and Immunology
Term: 01/04/2017 – 03/31/2020
Professor of Medicine
Surgery and Immunology
University of Pittsburgh
Pittsburg, PA

Acting Designated Federal Official
Prabhakara Atreya, Ph.D.
Director, Division of Scientific Advisor and Consultants
Center for Biologics Evaluation and Research, FDA
10903 New Hampshire Avenue
Silver Spring, MD 20993

Dale Ando, M.D.*
Expertise: Industry Representative
Term: 04/01/2015 - 03/31/2019
Vice President
Therapeutic Development and Chief Medical Officer
Sangamo Biosciences, Inc.
Richmond, CA

Kenneth I. Berns, M.D., Ph.D.
Expertise: Molecular Genetics, Microbiology, Viral Vectors and Gene Therapies
Term: 09/27/2018 – 3/31/2022
Distinguished Professor Emeritus, Molecular Genetics and Microbiology
University of Florida
Gainesville, FL

Catherine Bollard, M.D., MBChB
Expertise: Pediatric Oncology,
Blood Marrow Transplants
Term: 09/30/2015 – 03/31/2019
Director, Program for Cell Enhancement
And Technologies for Immunotherapy
Children’s National Medical Center
Washington, DC

Christopher K. Breuer, M.D.
Expertise: General Surgery and Pediatric Surgery
Term: 03/31/2018 – 03/31/2022
Nationwide Children’s Hospital
Columbus, OH 43205

Randy Hawkins, M.D. **
Expertise: Consumer Representative
Term: 04/01/2017 – 03/31/2021
Private Practice
Inglewood, CA

Daniel Longo, M.D.
Expertise: Hematology
Term: 04/01/2017 – 03/31/2021
Professor of Medicine
Senior Physician
Brigham and Women’s Hospital
Boston, MA

Sean J. Morrison, Ph.D.
Expertise: Stem Cell Biology
Term: 03/31/2018 – 03/31/2022
Children’s Research Institute
University of Texas Southwestern Medical Center
Dallas, TX, 75390

Raymond Roos, M.D.
Expertise: Neurology
Term: 04/01/2017 – 03/31/2020
Marjorie and Robert E. Straus Professor in Neurological Science
Department of Neurology
University of Chicago
Chicago, IL

Jan Stegemann, Ph.D.
Expertise: Biomedical Engineer
Term: 06/06/2016-03/31/2020
Department of Biomedical Engineering
University of Michigan
Ann Arbor, MI 

Mark C. Walters, M.D.
Expertise: Hematology and Oncology, Blood and Bone Marrow Transplantation, and Stem Cell Biology
Term: 09/27/2018 – 03/31/2022
Jordan Family Director Blood and Marrow Transplantation
USCF Benioff Children’s Hospital Oakland
Oakland, CA

Robert F. Willenbucher, M.D., M.B.A.***
Expertise: Alternate Industry Rep.
Term: 04/01/2015 – 03/31/2019
Head of Janssen Incubator
Johnson & Johnson, New Brunswick, NJ
Janssen Research & Development, LLC, Radnor, PA

Janet Wittes, Ph.D.
Expertise: Biostatistics and Mathematical Sciences
Term: 11/18/2015 - 03/31/2019
Statistical Collaborative, Inc.
Washington, DC

Joseph Wu, M.D., Ph.D.
Expertise: Cardiology and Radiology
Term: 12/12/2016 – 03/31/2020
Director, Stanford Cardiovascular Institute and
Professor of Medicine and Radiology
Stanford University
Stanford, CA

John A. Zaia, M.D.
Expertise: Virology and Infectious Disease
Term: 03/31/2018 – 03/31/2022
Director, Center for Gene Therapy, Hematologic Malignancies and Stem Cell Tran.
Department of Hematology, Aaron D. and Edith Miller Chair in Gene Therapy
Institutional Official, Beckman Research Institute of City of Hope
Duarte, CA 91010

Committee Management Specialist
Joanne Lipkind, M.S.

Division of Scientific Advisor and Consultants
Center for Biologics Evaluation and Research, FDA
10903 New Hampshire Avenue
Silver Spring, MD 20993

* Industry Representative
** Consumer Representative
*** Alternate Industry Representative
**** Chairperson

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 10/12/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English